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Background/Aims
The prevalence of diagnosed gastroparesis is 24.2/100,000 inhabitants, but a large group of people with gastroparesis-like 
symptoms have never had a gastric emptying (GE) test. Some of them may have undiagnosed gastroparesis. Our aim was to 
estimate the prevalence of hidden gastroparesis in the community.
Methods
The study was conducted in 2 parts: (1) Patients referred for a scintigraphic GE test completed a validated questionnaire 
(Bowel Disease Questionnaire). Multiple linear regression models to predict 2 hours and 4 hours GE rates were developed. (2) 
A revised Bowel Disease Questionnaire was mailed to a random sample of 4,194 Olmsted County residents. GE rates were esti-
mated with the models for each subject and delayed GE was considered when they were lower than normal values. Hidden 
gastroparesis was defined in community subjects with predicted delayed GE that had not been diagnosed with gastroparesis 
prior to the survey. 
Results
The regression models for GE rates were constructed using data from 450 patients. In addition to age and gender, the symp-
toms found significant were nausea/vomiting, early satiety, upper abdominal pain, bloating, loss of appetite and weight loss 
more than 7 pounds. 2,298 (55%) community subjects returned a questionnaire. Five subjects were excluded due to a prior 
diagnosis of gastroparesis. When models were applied to the community survey data, 42 (1.8%) subjects were estimated to 
have delayed GE.
Conclusions
Delayed GE was estimated to occur in 1.8% of community subjects. Since the prevalence of diagnosed gastroparesis is low 
(0.02%), many subjects with gastroparesis may remain undiagnosed. 
(J Neurogastroenterol Motil 2012;18:34-42)
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Introduction
Gastroparesis is a chronic symptomatic gastric disorder char-
acterized by delayed gastric emptying (GE) in the absence of me-
chanical obstruction.
1 Any condition affecting neuromuscular 
dysfunction of the gastrointestinal (GI) tract can cause gastro-
paresis, although most frequently the condition is idiopathic or 
secondary to diabetes mellitus
2; other potential etiologies noted 
among 146 cases
3 included post-surgery (13%), Parkinson’s dis-
ease (7.5%), collagen vascular disorders (4.8%), intestinal pseu-
doobstruction (4.1%) and rare other causes (6%).
Symptoms of gastroparesis are variable but typically are 
thought to include nausea, vomiting, early satiety, postprandial 
bloating/fullness or upper abdominal discomfort.
1,2 Nausea was 
reported by more than 90% of patients with gastroparesis, vomit-
ing by 68%-84% and bloating by 75%, in 2 case series.
3,4 Severe 
cases may also suffer from dehydration, electrolyte disturbances, 
weight loss and malnutrition; other complications include esoph-
agitis, Mallory-Weiss syndrome and bezoars.
1 Gastroparesis 
symptoms reduce quality of life, and there is a correlation be-
tween severity of symptoms and impairment of quality of life.
5,6 
Delayed GE is traditionally considered as the major pathophysio-
logical mechanism underlying symptoms in patients with gastro-
paresis,
7 although abnormal fundic accommodation may be also 
important.
8
The correlation between symptoms and delayed GE is con-
troversial. Some studies detected an association between delayed 
GE and female gender, postprandial fullness, nausea and vomit-
ing in patients with dyspepsia,
9-15 while others did not.
16-19 
Similarly, GE rates in diabetic patients were predicted by ab-
dominal bloating/fullness and female gender in one study
20 and 
associated with postprandial fullness and abdominal pain in 
another.
21 Therefore, we hypothesized that a model to predict 
GE rate can be constructed based on symptoms and demographic 
variables.
The prevalence of gastroparesis is unknown due to the diffi-
culties inherent of undertaking true population based studies, 
since we lack an easy-to-use, generally available GE test than can 
be applied widely. Although gastroparesis is recognized to cause 
increased hospitalizations and carries high associated costs in the 
USA,
22 little incidence and prevalence data on gastroparesis are 
available. Recently, using the unique resources of the Rochester 
Epidemiology Project, the epidemiology of gastroparesis in the 
community was studied; we found that definite gastroparesis 
(defined as typical symptoms plus confirmed delayed GE by 
scintigraphy) had a prevalence of 24.2 per 100,000 inhabitants, 
and an incidence 6.3 per 100,000 persons per year.
23 It is known, 
however, that gastroparesis-like symptoms are much more com-
mon in the community than the observed documented incidence 
and prevalence rates. A population-based survey in Olmsted 
County observed a prevalence of upper abdominal pain of 7.8%, 
while 7% had early satiety.
24 In a North American population 
sample, 7% complained of nausea/vomiting in the previous three 
months,
25 while chronic nausea was reported by 4% and chronic 
vomiting by 2%.
26 Among subjects with diabetes mellitus, 
11%-18% reported symptoms consistent with upper GI dys-
motility.
27-29 Gastroparesis-like symptoms are thus highly preva-
lent in the community but how many of these people have gastro-
paresis is uncertain.
We know that there is a large group of people with gastro-
paresis-like symptoms who have never had a GE test and are un-
likely to submit to such testing. Many of these subjects may have 
unrecognized (or hidden) gastroparesis, mirroring the iceberg ef-
fect seen in gastroesophageal reflux disease (GERD),
30 irritable 
bowel syndrome
31 and celiac disease.
32 We hypothesized that gas-
troparesis is more common in the community than has been sus-
pected; therefore, the aim of this study was to estimate the likely 
prevalence of hidden gastroparesis in a representative U.S. 
community.
Materials and Methods
This study consisted of 2 parts: first, a model to predict GE 
rate was developed, and second, we applied this model to com-
munity subjects in order to estimate the prevalence of likely hid-
den gastroparesis. This study was approved by the institutional 
review boards of the Mayo Foundation and the Olmsted 
Medical Center.
Part 1. Development of a Model to Predict 
Gastric Emptying Rate
Unselected patients (not necessarily county residents) re-
ferred for a GE scintigraphic test in 1996 were considered for in-
clusion in Part 1. Medical charts were reviewed to exclude those 
patients with mechanical gastric outlet obstruction. They com-
pleted a version of the validated Talley Bowel Disease Question-
naire (BDQ), which includes information regarding upper and 
lower GI symptoms; its reliability and validity have been pre-
viously shown.
33,34Enrique Rey, et al
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GE of solids was measured using a gastric scintigraphic 
method that has been validated and reported previously.
35 Briefly, 
the study began with patients under fasting conditions for a mini-
mum of 6 hours. A radiolabeled meal was prepared by adding 
0.75 mCi 
99mTc-sulfur colloid to 2 raw eggs prior to cooking. A 
meal containing these eggs on 1 slice of buttered bread was 
served along with a 240 mL glass of 1% milk (total calories: 296 
kcal, 32% protein, 35% fat and 33% carbohydrate). Anterior and 
posterior gamma camera images were obtained immediately after 
meal ingestion and then at 1, 2 and 4 hours. The geometric mean 
of delay-corrected counts in anterior and posterior images of the 
stomach was used to estimate the proportion of 
99mTc emptied at 
each time point.
Two multiple linear regression models to predict GE rates 
(defined as the percentage of 
99mTc having left the the stomach) 
at 2 hours and separately at 4 hours were developed. The follow-
ing self-reported symptoms, along with age and gender, were 
considered for inclusion in the models as potential predictors: 
(1) Nausea - recorded on the questionnaire as: None, Less 
than once a month, About once a month, About once a week, 
Several times a week, or Daily and coded as ≥ weekly (Yes/No) 
for the model development.
(2) Vomiting - recorded using the same categories and coded 
the same way in the model.
(3) Early satiety - elicited as self-reported inability to finish a 
regular meal recorded as: Never, Sometimes (＜ 25% of the 
time), Often (＞ 25% of the time) or Usually (＞ 75% of the 
time) and coded as often or usually (Yes/No).
(4) Bloating - elicited as perception of abdominal distention 
or actually seeing the abdomen distended categorized and coded 
the same way as early satiety.
(5) Upper abdominal pain - elicited as pain in the abdomen 
above the umbilicus, without lower abdominal pain (below the 
umbilicus), recorded as: Less than once a month, About once a 
month, About once a week, Several times a week, or Daily. This 
was coded as ≥ about once a month.
(6) Unwanted weight loss - elicited as: No, ＜ 7 lb, or ≥ 7 lb 
and was coded as an undesired loss of 7 lb or more (Yes/No).
(7) Self reported loss of appetite in the last year (Yes/No).
(8) Abdominal pain made worse with food - recorded as: 
Never, Sometimes (＜ 25% of the time), Often (＞ 25% of the 
time), or Usually (＞ 75% of the time) and coded as often or usu-
ally (Yes/No).
In addition, age and gender were included as covariates in the 
model. Since virtually all of the subjects undergoing a scinti-
graphic GE test reported one or more specific upper GI symp-
toms, the classification of delayed vs non-delayed GE was based 
on the observed GE rates at 2 and 4 hours, and then models using 
primarily symptoms were developed to predict these observed 
rates.
Part 2. Application of the Model to Commu-
nity Subjects
In 2003 and 2004, a Talley BDQ was mailed to a cohort of 
community subjects that had been randomly chosen and mailed 
various GI disease questionnaires 10 to 15 years earlier (n = 
9,327). Subjects who had died (n = 1,685), moved from 
Olmsted County (n = 1,056), denied authorization to use their 
medical records for research (as required by Minnesota law) (n 
= 331), ＞ 80 years old (n = 691), and subjects who had re-
sponded to (n = 659) or explicitly refused (n = 45) an earlier 
(2001) follow-up questionnaire, or identified post mailing as in-
eligible (n = 551) were excluded from the cohort for the 
2003-2004 mailing. A modified Talley BDQ was mailed to eligi-
ble community subjects. Reminder letters were mailed at 2, 4 and 
7 weeks. Subjects who indicated at any point that they did not 
wish to complete the survey were not contacted further. 
Nonresponders were contacted by telephone at 10 weeks to re-
quest their participation and verify their residence within the 
county. Subjects who completed the survey were offered $5 
remuneration. The questions used to define the symptoms used 
in model development were included in the modification of the 
Talley BDQ and were identical to the Talley BDQ version 
mailed in the population follow-up survey.
For each community subject, the GE rates at 2 and 4 hours 
were estimated applying the model previously developed. The es-
timated GE rates in community subjects were used to classify 
these subjects as “delayed” (vs non-delayed) GE using accepted 
clinical cut-off values. The classification of delayed vs non-de-
layed GE in community subjects was defined as estimated GE 
rates at 2 hours slower than 40% or at 4 hours slower than 84%.
36 
Thus, hidden gastroparesis was defined in community subjects as 
those subjects with predicted values of GE at 2 or 4 hours based 
the model).
Statistical Methods
The accuracy for predicting delayed GE was summarized for 
the sample of patients from Part 1 of the study by calculating pre-
dicted values for the GE rate at 2 and 4 hours for each subject in-
cluded in the development dataset (scintigraphic GE test pa-Prevalence of Hidden Gastroparesis
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Figure 1. Distribution of gastric emptying rate at 2 and 4 hours in the 
450 patients evaluated.
Table 1. Symptoms Reported by the 450 Subjects Included for the
Construction of Gastric Emptying Model, Classified as Delayed 





GE (n = 334)
Nausea/vomiting   96 (92.3%
a) 187 (56%)
Early satiety   88 (84.6%
b) 241 (72.2%)
Bloating   68 (65.4%) 234 (70.1%)
Upper abdominal pain   47 (45.2%
a)   85 (25.4%)
Upper abdominal pain worsen by food     9 (8.7%
b)   72 (21.6%)
Unwanted weight lost   37 (35.6%
a) 188  (56.3%)
Loss of appetite    73 (70.2%
a) 163 (48.8%)
Lower/diffuse abdominal pain
c   45 (43.3%
b) 183 (54.8%)
Constipation
c   53 (51.0%) 166 (50.3%)
Diarrhea
c   29 (27.9%) 121 (36.8%)
Heartburn (weekly)
c   36 (35.0%) 121 (36.6%)
Regurgitation
c   75 (72.1%
b) 188 (56.5%)
aP ＜ 0.001(Fisher’s exact test) for association of GE status and symptom, 
bP ＜
0.05 (Fisher’s exact test) for association of GE status and symptom, 
cThese 
variables were not included in the multiple linear regression prediction model.
GE, gastric emptying.
tients, all but one of these subjects reporting one or more upper 
GI symptoms). These predicted GE emptying rates were then 
used to generate an receiver operating characteristic (ROC) 
curve by incorporating them in a binary logistic regression model 
in which the response (binary dependent variable) was “delayed 
vs non-delayed GE” defined using the actual 2 and 4 hour GE 
rates and the clinical cut-off values of 0.4 and 0.84, respectively. 
The results from the linear regression models (to predict GE 
at 2 and separately 4 hours) were used to estimate the proportion 
of people from the community survey who would be expected to 
have delayed gastric emptying.
The association of GE status (delayed vs non-delayed) with 
specific symptoms was assessed using contingency table analyses 
(Chi-square test statistics or Fisher’s exact test as warranted) in 
the GE test patients and separately in the community ques-
tionnaire respondents. The alpha level for statistical significance 
was a (two-sided) alpha level of 0.05.
Results
Part 1. Development of a Model to Predict 
Gastric Emptying Rate
Data from 450 patients were analyzed. Three hundred and 
thirty (73%) were females and their mean age was 46 ± 17 (range 
10-85). Four hundred and 49 patients (99.8%) suffered upper 
GI symptoms, and most had several symptoms: 9 (2.0%) had 1 
symptom, 27 (6.0%) had 2 symptoms, 41 (9.1%) had 3 symp-
toms, 55 (12.2%) had 4 symptoms, 52 (11.6%) had 5 symptoms, 
70 (15.6%) had 6 symptoms, 67 (14.9%) had 7 symptoms, 77 
(17.1%) had 8 symptoms, 28 (6.2%) had 9 symptoms, 21 (4.7%) 
had 10 symptoms and 2 (0.4%) had 11 symptoms. Table 1 shows 
the frequency of each upper GI symptom in the clinical group re-
ferred for a GE test.
Median (range) GE rate at 2 hours was 42% (28%-56%) and 
80% at 4 hours (58%-90%). Figure 1 shows the distribution of 
GE rate at 2 hours (X-axis) vs 4 hours (Y-axis). Overall, 104 pa-
tients showed GE below the clinical cut off values at both 2 and 4 
hours.
The regression models for the 2 and 4 hour GE rates were 
constructed using data from these patients. In addition to age and 
gender, the symptoms used in the prediction models (upper por-
tion of Table 1) for the 2 and 4 hour GE rate included early sati-
ety, upper abdominal pain, pain made worse with food and loss of 
appetite. Table 2 shows the results of these models. Of note, a 
negative coefficient means a lower gastric emptying rate and thus 
more likely gastroparesis.
Figure 2 shows the ROC curve obtained from the logistic re-
gression model using predicted 2 and 4 hour GE rates. Using the 
clinical lab cut-off points, a sensitivity of 25% and a specificity of 
77% was obtained. The ROC curve is better than expected by 
chance. The curve is the best approximation of gastric emptying 
values from the models that were developed.Enrique Rey, et al
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Figure 3. Distribution of predicted gastric emptying at 2 and 4 hours in
community subjects.
Figure 2. Receiver operating characteristic curve using the predicted 2
and 4 hour gastric emptying rates for identifying delayed gastric 
emptying.
Table 2. Multivariable Models for Predicting Gastric Emptying 
Rate at 2 and 4 Hours
Predictive model Coefficient ± SE
2 hr GE predictive model
    Age 0.13 ± 0.06
    Gender 1.26 ± 2.35
    Early satiety 0.42 ± 2.77
    Upper abdominal pain -7.24 ± 3.32
    Pain made worse with food 9.29 ± 3.84
    Loss of appetite -4.26 ± 2.34
    Nausea/vomiting -4.81 ± 2.37
    Weight loss 4.09 ± 2.21
    Bloating 1.19 ± 2.26
Adjusted R-square = 0.03
4 hr GE predictive model
    Age  0.06 ± 0.06
    Gender  2.32 ± 2.23
    Early satiety -1.85 ± 2.63
    Upper abdominal pain -11.71 ± 3.02
    Pain made worse with food 10.69 ± 3.60
    Loss of appetite -3.60 ± 2.21
    Nausea/vomiting -2.00 ± 2.24
    Weight loss -0.83 ± 2.08
    Bloating -0.75 ± 2.13
Adjusted R-square = 0.04
Note that negative coefficients predict slower GE rate.
GE, gastric emptying.
Table 3. Symptoms Reported by Community Subjects With 




GE (n = 42)
Predicted non-delayed 
GE (n = 2,177)
Nausea/vomiting 16 (38.1%)
a   53 (2.4%)




Upper abdominal pain 34 (81.0%)
a 125 (5.7%)
Abdominal pain worsen   0 (0%)   53 (2.4%)
 by food
Unwanted weight lost   1 (2.4%) 106 (4.9%)
Loss of appetite 16 (38.1%)
a 164 (7.5%)




b   2 (4.8%)   37 (1.7%)
Diarrhea







aP ＜ 0.001 (Fisher’s exact test) for the association of GE status and symptoms, 
bThese variables were not included in the predictive model.
GE, gastric emptying.
Part 2. Application of the Model to Commu-
nity Subjects
Surveys were mailed to 4,194 community subjects and 2,298 
returned the questionnaire; therefore, the response rate was 
54.8%. Six subjects were excluded due to a prior diagnosis of de-
finitive or probable gastroparesis by chart review and 73 subjects 
were not included in the analysis for delayed GE because of miss-
ing data.
When these models were applied to the remaining 2,219 
community subjects (Fig. 3), 42 (1.8%) were estimated to have 
delayed GE based on applying the clinical cut-offs to the 2 and 4 
hour predicted rates. To be classified as delayed GE, a person in 
the community had to be estimated to have either a 2 or 4 hour Prevalence of Hidden Gastroparesis
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delayed in GE. Among the subjects with predicted delayed GE, 
33 (79%) were women, and their mean (± SD) age was 52.8 ± 
11.3 years. In comparison, among the 2,177 community subjects 
classified as non-delayed GE, 1,126 (51.7%) were women, with a 
mean (± SD) age of 62.4 ± 12.2. Symptoms reported by these 
subjects are summarized in Table 3.
All 42 subjects with predicted delayed GE were sympto-
matic: 12 (28.6%) had 1 symptom, 8 (19.1%) had 2 symptoms, 8 
(19.1%) had 3 symptoms, 5 (11.9%) had 4 symptoms, 7 (16.7%) 
had 5 symptoms, 1 (2.4%) had 6 symptoms and 1 (2.4%) had 7 
symptoms. Mild nausea or vomiting (less than weekly) was re-
ported by 20 of 42 (47.6%) subjects with predicted delayed GE, 
compared to 660 of 2,177 (30.3%) subjects with predicted 
non-delayed GE (P ＜ 0.001). Forty of 42 (95.2%) subjects with 
predicted delayed GE met criteria for dyspepsia, while 301 of 
2,177 (13.8%) subjects without predicted delayed GE met dys-
pepsia criteria. 
Predicted delayed GE was significantly associated with 
physician visits in the last 10 years for upper GI symptoms 
(overall 24% of subjects with delayed GE vs 10% of subjects with 
non-delayed GE; P = 0.008), although no association was de-
tected in subjects with dyspepsia (25% vs 17%; P = 0.280). 
There was also a significant association between predicted de-
layed GE and having an EGD in the last 10 years (29% of sub-
jects with predicted delayed GE vs 16% of subjects with non-de-
layed; P = 0.030), although no association was found in subjects 
with dyspepsia (30% vs 29%; P = 0.850).
Discussion
The prevalence of definitive gastroparesis in the community 
has been reported to be 24.2 per 100,000 and only increased to 
50.5 per 100,000 if probable and possible cases were included.
23 
We observed in this study that hidden gastroparesis may occur in 
1.8% of community subjects; therefore, the proportion of sub-
jects with diagnosed gastroparesis may reflect only the tip of the 
iceberg in the community.
One study reported that gastroparesis-related hospital-
izations have increased in recent years
22; this observation could be 
due to a growing incidence, but we previously found no sig-
nificant change in the incidence of gastroparesis in recent deca-
des,
23 suggesting that the increase in hospitalizations may be 
more related to changes in management and codification issues. 
Our estimation of the prevalence of hidden gastroparesis streng-
thens this explanation but emphasizes that this may already be a 
huge problem; what it is likely to change in the future is the num-
ber of cases diagnosed with gastroparesis.
It may be argued that the 1.8% of subjects identified as likely 
having gastroparesis may just reflect the proportion of “healthy” 
subjects that would lie below the normal cut-off of a test. 
However, our model would have not identified asymptomatic 
subjects because it relies on symptoms and a priori; it would have 
been possible that no subject in the community reported enough 
symptoms. Notably, the prevalence of symptomatic subjects with 
delayed GE (1.8%) estimated by our model is close to the 3% 
prevalence that could be inferred from the only small US study 
that has actually applied the physiologic test in a community 
sample.
37
This iceberg effect has been previously recognized in several 
diseases, but in the case of gastroparesis, this seems to be im-
pressive; around 2% of the population is predicted to have a de-
layed GE. The reason for the hidden part of the iceberg in other 
diseases like gastroesophageal reflux disease and celiac disease is 
mainly the lack of consultation for mild symptoms or no symp-
toms.
30,38 In the case of hidden gastroparesis, consultation rates 
were similar to community subjects with dyspepsia not predicted 
to have delayed GE. In addition, those with a pattern suggestive 
of gastroparesis were not more likely to have an esophagogas-
troduodenoscopy done. Our data suggests that the diagnostic ap-
proach when subjects with gastroparesis like features consult is 
not different from other subjects with dyspepsia, but it does not 
usually include a GE test.
Subjects predicted to have delayed GE were predominantly 
women and all of them were symptomatic. However, the symp-
tom profile is somewhat different to what is described in series of 
patients diagnosed with gastroparesis.
3,4 Subjects with predicted 
delayed GE are more likely to report upper abdominal pain and 
less frequently, nausea and vomiting. Upper abdominal pain has 
been previously reported to occur in 46% of gastroparesis pa-
tients,
3 although higher rates have also been observed.
4 Thus, the 
reporting of upper abdominal pain by 81% of subjects with pre-
dicted GE in the community is not totally unexpected. More than 
90% of patients with gastroparesis in the first part of our study re-
ported nausea and vomiting similar to other case series.
3,4 
However, only 38% of subjects with hidden gastroparesis re-
ported nausea and vomiting on a weekly basis, although mild 
nausea and vomiting was reported by an additional 48%. The 
most likely explanation is that these subjects are less likely to con-
sult because of milder symptoms. 
It may be argued that frequency of symptoms is just the Enrique Rey, et al
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mathematical expression of the model. It is true that the model is 
based on symptoms, and asymptomatic subjects would not have 
been predicted to have slow 2- and 4-hour GE rates. However, 
the application of the model identified those subjects in the com-
munity with certain combinations of symptoms yielding slow 2- 
and 4-hour predicted GE rates; a priori, it was unknown which 
symptom combinations will occur in the community and how 
many subjects would report each particular combination. Thus, 
the frequencies of symptoms in community subjects with pre-
dicted delayed GE could not be known a priori with just the 
mathematical model.
The clinical differences between functional dyspepsia and 
gastroparesis are not well defined; symptoms of gastroparesis 
overlap with those of functional dyspepsia.
1 Delayed GE has been 
reported in 23%-33% of patients with functional dyspep-
sia,
10,12,14,16,39,40 although the clinical significance is uncertain. 
However, it cannot be assumed that a third of community sub-
jects with dyspepsia would have a delayed GE. Our data suggest 
that 12% of community subjects with dyspepsia would be pre-
dicted to have delayed GE; this is in accordance with the reported 
prevalence of 17% in a study, which actually measured GE in a 
small sample of community subjects with dyspepsia.
37
Several studies have previously looked for an association be-
tween GE and symptoms, mostly in samples of patients diag-
nosed with functional dyspepsia; some of them did not find any 
association,
9-15 while others did detect a link.
16-19 However, asso-
ciations found in these latter studies were not strong and were 
somewhat discrepant in terms of what symptoms are associated 
with delayed GE. Thus, it is not surprising that the associations 
found with our model were not strong; just 3%-4% of the varia-
bility in GE rate was explained by the model. The model is there-
fore not clinically suitable for the identification of people with de-
layed GE and it is not a substitute for a GE test. However, it may 
serve to provide a good estimation of GE in a scenario where ap-
plication of scintigraphic testing is not amenable.
Our study has several strengths. First, the clinical sample 
used for generating the model is large, and, in fact, is among the 
largest series testing for associations between symptoms and 
GE.
10,11,16,19 Also, unlike previously reported series, patients were 
selected based on medical referral for a GE test, and all consec-
utive patients were included; this implies that symptoms reported 
by our patients are not restrained by any specific symptom or 
combinations of symptoms, but just on what physicians consid-
ered clinically suspicious for delayed GE. Also, our model was 
developed to predict the GE rate rather than directly identify 
subjects with predicted delayed GE, which requires a different 
approach. Information was collected though a well validated 
questionnaire and questions regarding symptoms were the same 
in both the clinical and the community samples. Finally, the com-
munity sample was selected at random from the population, and it 
is well characterized through the resources of the Rochester 
Epidemiology Project; specifically a previous diagnosis of prob-
able or definitive gastroparesis and mechanical gastric ob-
struction can be ruled out, helping assure that the “hidden” tag 
for these community subjects is correct.
Notably, there are some limitations. First, the optimal way to 
know exactly the prevalence of hidden gastroparesis would re-
quire the direct measurement of GE in a large community sam-
ple; however, it is not feasible to do a GE test in a large commun-
ity sample due to low recruitment rates. Alternative methods to 
objectively measure the GE rate also require subjects to attend 
specialized centers (ultrasonography and MRI) or are time con-
suming for them (breath test). Second, the ideal sample to devel-
op the model would have been a random sample from the 
community. However, a large sample would still be required, and 
probably would never be recruited; therefore, the best alternative 
was a symptomatic model for predicting GE as a first step. The 
use of a sample based upon referral for a GE test may lead to an 
overestimation of delayed GE; for that reason, we chose a con-
servative approach requiring both 2- and 4-hour emptying rates 
below the cut-offs to consider that a subject have a predicted de-
layed GE; in fact, the predictive model showed a poor sensitivity 
but in exchange we gained reasonable specificity, making us con-
fident that few of the subjects predicted to have delayed GE 
would be false positive. Although the sample used for generating 
the model differs from community samples in terms of age 
(younger) and gender distribution (predominance of females), 
these differences are unlikely to have a major impact in the re-
sults, since the model predicts slower GE for younger subjects 
and females. Finally, as mentioned above, the model for GE is 
not as accurate as we would like, but this is not surprising in view 
of the discrepancies reported in the literature.
9-19
Our data should be interpreted as estimation and not as true 
prevalence data. We have shown however that known gastro-
paresis is likely just the tip of a large hidden iceberg, which in-
cludes both subjects that do not consult and those in whom de-
layed GE is not clinically identified.Prevalence of Hidden Gastroparesis
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